Related Experiment Videos
Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration
Insights
Haloperidol effectively treats autistic children long-term. Discontinuous administration proved as effective as continuous treatment, particularly for irritability and uncooperativeness.
Area of Science:
- Child Psychiatry
- Developmental Neuroscience
- Pharmacology
Background:
- Autism Spectrum Disorder (ASD) presents significant behavioral challenges.
- Pharmacological interventions are often necessary for managing severe symptoms in autistic children.
- Haloperidol is a commonly used antipsychotic for managing behavioral disturbances in ASD.
Purpose of the Study:
- To assess the long-term effectiveness of haloperidol in children with autism.
- To compare the efficacy of continuous versus discontinuous haloperidol administration.
- To identify specific symptom profiles that predict positive response to haloperidol.
Main Methods:
- A 6-month treatment period with haloperidol followed by a 4-week placebo/withdrawal phase.
- Inclusion of 60 children (ages 2.3-7.9 years) diagnosed with autism.
- Evaluation of treatment efficacy based on symptom response, particularly irritability and uncooperativeness.
Main Results:
- Haloperidol demonstrated sustained efficacy over the 6-month study period.
- Discontinuous drug administration was found to be as effective as continuous administration.
- Children exhibiting significant irritability, emotional lability, and uncooperativeness showed the best response to haloperidol.
Conclusions:
- Long-term haloperidol treatment is effective for managing challenging behaviors in autistic children.
- A discontinuous dosing schedule maintains therapeutic benefits without compromising efficacy.
- Targeting specific symptoms like irritability can optimize haloperidol treatment outcomes in ASD.
Abstract:
The aim of this study was to evaluate the long-term efficacy of haloperidol in autistic children and to determine whether discontinuous drug administration was as effective as continuous drug administration. Sixty children, 48 males and 12 females, ages 2.3 to 7.9 years (X 5.1) completed the study. They received haloperidol over a period of 6 months followed by a 4-week drug withdrawal/placebo period. Haloperidol remained effective, and the discontinuous treatment schedule did not diminish its efficacy. Children with prominent symptoms of irritability, angry and labile affect, and uncooperativeness were the best responders to haloperidol.